TNFRSF1B and neoplasm: Ligand TNF and its receptor TNFRSF1B were found to act as major signaling from CD4+ T cells to CD8+ T2/T3 cells, and the ability of the TNF–TNFRSF1B pair to kill tumor cells in vitro has been reported before (28).